Tumor-self-targeted “thermoferroptosis-sensitization” magnetic nanodroplets for multimodal imaging-guided tumor-specific therapy

Ferroptosis-based nanomedicine has drawn increasing attention in antitumor therapy because of the advantages of this unconventional mode of apoptosis, but the difficulties of delivery to the tumor site and surface-to-core penetration after arrival seriously hinder further clinical transformation and...

Full description

Saved in:
Bibliographic Details
Published in:Biomaterials 2021-10, Vol.277, p.121100, Article 121100
Main Authors: Wang, Junrui, Song, Weixiang, Wang, Xingyue, Xie, Zhuoyan, Zhang, Wenli, Jiang, Weixi, Liu, Shuling, Hou, Jingxin, Zhong, Yixin, Xu, Jie, Ran, Haitao, Guo, Dajing
Format: Article
Language:English
Subjects:
Cell Line, Tumor
Ferroptosis
Hyperthermia, Induced
Magnetic fluid hyperthermia
Magnetic nanodroplets
Magnetic Phenomena
Multimodal Imaging
Nanomedicine
Nanoparticles
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ferroptosis-based nanomedicine has drawn increasing attention in antitumor therapy because of the advantages of this unconventional mode of apoptosis, but the difficulties of delivery to the tumor site and surface-to-core penetration after arrival seriously hinder further clinical transformation and application. Herein, we propose an unprecedented strategy of injecting magnetic nanodroplets (MNDs) to solve these two longstanding problems. MNDs are nanocarriers that can carry multifunctional drugs and imaging materials. MNDs can effectively accumulate in the tumor site by active tumor targeting (multifunctional drugs) and passive tumor targeting (enhanced permeability and retention effect), allowing diffusion of the MNDs from the surface to the core through mild-temperature magnetic fluid hyperthermia (MHT) under multimodal imaging guidance. Finally, the ferroptosis pathway is activated deep within the tumor site through the drug release. This approach was inspired by the ability of mild-temperature MHT to allow MNDs to quickly pass through the blood vessel-tumor barrier and deeply penetrate the tumor tissue from the surface to the core to amplify the antitumor efficacy of ferroptosis. This strategy is termed as “thermoferroptosis sensitization”. Importantly, this behavior can be performed under the guidance of multimodal imaging, making the design of MNDs for cancer therapy safer and more reasonable.
ISSN:0142-9612
1878-5905
DOI:10.1016/j.biomaterials.2021.121100